Key result
Transcatheter aortic valve implantation significantly reduced mitral regurgitation severity, with aFMR patients showing the greatest improvement.
Why the study?
Does transcatheter aortic valve implantation (TAVI) improve mitral regurgitation severity and symptoms across different MR aetiologies?
Does transcatheter aortic valve implantation (TAVI) improve mitral regurgitation severity and symptoms across different MR aetiologies?
TAVI effectively reduces mitral regurgitation severity and symptoms, with the most significant improvement seen in patients with atrial functional mitral regurgitation.
Answers are grounded in this paper and cite their sources.
TAVI was associated with reduced MR severity (greatest in aFMR); leaves open whether aetiology should guide decisions in mixed valve disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Doldi et al. (2023) studied this question. Transcatheter aortic valve implantation significantly reduced mitral regurgitation severity, with aFMR patients showing the greatest improvement.
Synapse has enriched 10 related papers. Consider them for comparative context: